Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$14.3B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$7.67B |
| 3 |
Microsoft
MSFT
|
+$7.3B |
| 4 |
Apple
AAPL
|
+$7.01B |
| 5 |
NVIDIA
NVDA
|
+$4.98B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.8% |
| 2 | Financials | 9.06% |
| 3 | Healthcare | 6.87% |
| 4 | Industrials | 6.79% |
| 5 | Consumer Discretionary | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENZ
4701
DELISTED
Enzo Biochem, Inc.
ENZ
| $12.2K | ﹤0.01% |
+17,016
| New | +$17.6K |
|
4702
Orion Energy Systems
OESX
$80.6M
| $12.1K | ﹤0.01% |
+1,506
| New | +$13.2K |
|
|
TMQ
4703
Trilogy Metals
TMQ
$656M
| $11.7K | ﹤0.01% |
+10,044
| New | +$9.03K |
|
4704
SKYX Platforms
SKYX
$164M
| $11.6K | ﹤0.01% |
+10,000
| New | +$11.4K |
|
4705
Milestone Scientific
MLSS
$42.6M
| $11.5K | ﹤0.01% |
+12,000
| New | +$9.91K |
|
|
BNKK
4706
Bonk Inc
BNKK
$8.4M
| $10.8K | ﹤0.01% |
+430
| New | +$14.8K |
|
|
BNAI
4707
Brand Engagement Network
BNAI
$95.3M
| $9.74K | ﹤0.01% |
+1,000
| New | +$8.68K |
|
4708
DarioHealth
DRIO
$71.2M
| $9.55K | ﹤0.01% |
+607
| New | +$10.5K |
|
4709
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$40.9B
| $9.5K | ﹤0.01% |
+100
| New | +$9.2K |
|
|
CMCT
4710
Creative Media & Community Trust
CMCT
$13M
| $8.96K | ﹤0.01% |
+2
| New | +$18K |
|
4711
Lexicon Pharmaceuticals
LXRX
$1.1B
| $8.8K | ﹤0.01% |
+11,912
| New | +$14.4K |
|
4712
CALL
Upstart Holdings
UPST
$3.03B
| $8.75K | ﹤0.01% |
+500
| New | +$31.2K |
|
4713
PUT
Lam Research
LRCX
$390B
| $7.4K | ﹤0.01% |
+100
| New | +$7.58K |
|
4714
Tiziana Life Sciences
TLSA
$127M
| $6.96K | ﹤0.01% |
+10,000
| New | +$9.25K |
|
|
FTH
4715
Faeth Therapeutics
FTH
$629M
| $6.86K | ﹤0.01% |
+700
| New | +$7.02K |
|
4716
Bionano Genomics
BNGO
$13.3M
| $5.7K | ﹤0.01% |
+329
| New | +$5.62K |
|
4717
CALL
Coupang
CPNG
$29.2B
| $5.5K | ﹤0.01% |
+200
| New | +$4.91K |
|
|
WBX
4718
Wallbox
WBX
$81.5M
| $5.11K | ﹤0.01% |
+510
| New | +$8.07K |
|
4719
Biomerica
BMRA
$4.98M
| $4.52K | ﹤0.01% |
+1,881
| New | +$4.96K |
|
4720
GEE Group
JOB
$22.5M
| $3.73K | ﹤0.01% |
+18,000
| New | +$4.46K |
|
4721
Volato Group
SOAR
$7.23M
| $2.94K | ﹤0.01% |
+480
| New | +$3.29K |
|
Similar funds
Raymond James Financial's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Raymond James Financial, which disclosed 4,789 positions worth $271B. Its ten largest holdings account for 22% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 26,415,302 shares worth $14.2B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Financials and Healthcare.
- Raymond James Financial's largest Q4 2024 buy was Vanguard S&P 500 ETF: 26,415,302 shares worth $14.2B.
- Raymond James Financial's ten largest holdings make up 22% of its $271B portfolio in Q4 2024.
- Raymond James Financial disclosed 4,789 positions in Q4 2024, its first 13F filing on record.
Based on Raymond James Financial's 13F filing for Q4 2024, filed 6 Feb 2025.